What is the recommended mefenamic acid dose in mg per kilogram for children aged six months and older?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mefenamic Acid Dosing for Children

For children aged 6 months and older, the recommended dose of mefenamic acid is 4-6.5 mg/kg per dose, administered orally every 6-8 hours as needed for pain or fever.

Evidence-Based Dosing Recommendations

The FDA-approved dosing for mefenamic acid in adolescents ≥14 years is 500 mg initial dose followed by 250 mg every 6 hours 1. However, for younger children, the evidence supports weight-based dosing:

Optimal Pediatric Dose Range

  • 4 mg/kg per dose: Demonstrated optimal antipyretic efficacy in clinical trials 2, 3
  • 6 mg/kg per dose: Used effectively in comparative studies showing superior antipyretic effect versus paracetamol 4
  • 6.5 mg/kg per dose: Shown effective in head-to-head comparisons with other NSAIDs 5

The most commonly validated and recommended dose is 4-6 mg/kg per dose, given every 6-8 hours, not exceeding 4 doses in 24 hours.

Clinical Context and Comparative Efficacy

Research evidence demonstrates that mefenamic acid at 4-6 mg/kg provides:

  • Superior antipyretic effect compared to standard-dose paracetamol (10 mg/kg), with faster temperature reduction and longer duration of action 4
  • 2.5 times the antipyretic potency of acetylsalicylic acid or paracetamol at equivalent doses 3
  • Significantly better fever control than placebo, with measurable pain reduction at vaccination sites 6

The 6 mg/kg dose showed a mean temperature drop of 3.5°F over 4 hours, compared to 2.44°F with paracetamol and 2.79°F with ibuprofen 5.

Safety Considerations and Age Restrictions

Critical caveat: The FDA label does not establish safety and efficacy in children under 14 years for the approved indications 1. However, a study in preterm infants using 2 mg/kg showed a prolonged half-life (approximately 5 times longer than adults), indicating immature metabolic pathways 1.

Practical approach for children 6 months to 14 years:

  • Start with 4 mg/kg per dose for most indications
  • May increase to 6 mg/kg for more severe pain or fever if initial response inadequate
  • Administer every 6-8 hours as needed
  • Limit duration to 2-3 days for fever, up to 7 days maximum for pain
  • Avoid in children with renal impairment, hepatic dysfunction, or active GI disease

Administration Guidelines

  • Give with food or milk to minimize GI upset
  • Ensure adequate hydration
  • Monitor for adverse effects including GI symptoms, rash, or changes in urine output
  • Do not exceed maximum daily dose based on weight

Recent consensus from Indian pediatricians supports these dosing ranges while emphasizing the need for more robust long-term safety data in younger children 7. The pharmacokinetic profile shows mefenamic acid is >90% protein-bound with a 2-4 hour half-life in adults, though this may be prolonged in younger children 1.

Bottom line: Use 4-6 mg/kg per dose every 6-8 hours for children ≥6 months, with 4 mg/kg being the most evidence-supported starting dose for routine use.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.